DEA Block Of PDK Ephedrine Imports To Be Heard By Federal Appeals Court
This article was originally published in The Tan Sheet
Executive Summary
DEA's authority to block imports of pseudoephedrine based on concerns that finished products containing the ingredient will be diverted to meth production will be debated in a case facing the Federal Appeals Court for the D.C. Circuit this fall
You may also be interested in...
Industry-Wide Effect Of PSE Import Block “Not Relevant,” Judges Say
PDK Labs' assertion that a block on its bulk imports of pseudoephedrine by the Drug Enforcement Agency would extend beyond the agency's authority did not appear to sway federal judges who reviewed the case Jan. 10
Industry-Wide Effect Of PSE Import Block “Not Relevant,” Judges Say
PDK Labs' assertion that a block on its bulk imports of pseudoephedrine by the Drug Enforcement Agency would extend beyond the agency's authority did not appear to sway federal judges who reviewed the case Jan. 10
Industry-Wide Effect Of PSE Import Block “Not Relevant,” Judges Say
PDK Labs' assertion that a block on its bulk imports of pseudoephedrine by the Drug Enforcement Agency would extend beyond the agency's authority did not appear to sway federal judges who reviewed the case Jan. 10